glp-1 and type 2 diabetes GLP1-GIP receptor co-agonists: a promising evolution in the treatment of | Acta Diabetologica AdipoGen - Targeting GLP-1, GIP

Alexandra Sowa, MD of SoWell Health, who is a board certified obesity medicine expert and a clinical instructor of medicine at NYU, explained that its not surprising that a drug used to treat diabetes and obesity might also affect alcohol use disorder

It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists

G metodisk til vrks, ml dine resultater og justr lbende din tilgang, s din oplevelse forbliver bde sjov, tryg og velafbalanceret

10.1016/j.medj.2021.10.004 17 CorrealeM.LamacchiaO.CiccarelliM.DattiloG.TricaricoL.BrunettiN

As an oral GLP-1 therapy, it gives Lilly a way to reach patients who may not want Zepbound or other injectable options

In summary, the favourable effects of GLP-1MK-801 on glucose homeostasis seem to stem from both its incretin action and its weight-reducing effect